What are the contraindications for BiPAP (Bilevel Positive Airway Pressure) therapy in patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Contraindications for BiPAP Therapy

BiPAP should never be used in patients with apnea/impending respiratory arrest, inability to protect the airway, active vomiting, facial trauma/burns, fixed upper airway obstruction, or life-threatening hypoxemia unresponsive to high FiO2—these are absolute contraindications requiring immediate intubation instead. 1

Absolute Contraindications (Never Use BiPAP)

  • Apnea or impending respiratory arrest - the patient requires immediate intubation 1
  • Inability to protect the airway - risk of aspiration makes BiPAP dangerous 1
  • Active vomiting - high aspiration risk with positive pressure 1
  • Recent facial or upper airway surgery - disrupts surgical sites and healing 2
  • Facial burns or trauma - prevents adequate mask seal and causes tissue damage 1, 2
  • Fixed upper airway obstruction - positive pressure cannot overcome mechanical blockage 2
  • Life-threatening hypoxemia unresponsive to high FiO2 - BiPAP will not correct this; intubation needed 2

Relative Contraindications (Use With Extreme Caution or Avoid)

Cardiovascular Contraindications

  • Recent myocardial infarction - BiPAP may be associated with higher MI rates compared to CPAP in acute heart failure, though it can be used cautiously in selected cases 1, 3
  • Severe hypotension - positive pressure further reduces blood pressure regardless of volume status 3
  • Hemodynamic instability - requires ICU monitoring if BiPAP attempted 2

Pulmonary Contraindications

  • Pneumothorax - BiPAP must be discontinued until chest tube placement; can be used cautiously only after drain is in place 1, 2
  • Massive hemoptysis - BiPAP should be discontinued during active bleeding 1, 2

Neurological/Cooperation Issues

  • Inability to cooperate or follow commands - patient cannot maintain mask or signal distress 1
  • Severe agitation or altered mental status - prevents safe mask use 1
  • Inability to manage secretions - risk of aspiration with positive pressure 1

Special Disease Considerations

  • Acute Guillain-Barré syndrome with deteriorating respiratory function - BiPAP has failed catastrophically in case reports, with patients requiring emergency intubation after initial improvement; strongly avoid in progressing GBS 4
  • Obesity hypoventilation syndrome (OHS) - not a contraindication but requires liberal use of BiPAP with close monitoring due to higher risk of respiratory adverse events 5

Clinical Decision Algorithm

When BiPAP fails or is contraindicated:

  1. Proceed to intubation immediately if:

    • No improvement or worsening after 1-2 hours of BiPAP trial 1
    • Persistent or worsening hypercapnia with pH <7.25 1
    • Worsening mental status or inability to cooperate 1
    • Hemodynamic deterioration 1
    • Patient exhaustion despite BiPAP support 1
  2. In DNI (Do Not Intubate) patients: Absolute contraindications still apply, but relative contraindications can be overridden when invasive ventilation is not an option, with transition to comfort-focused care (opioids and anxiolytics) when BiPAP clearly fails 2

Common Pitfalls to Avoid

  • Poor mask fit leads to air leaks and treatment failure—mask selection is critical for success 1
  • Excessive pressure settings (IPAP >20 cmH2O or EPAP >8 cmH2O) can cause gastric distension or paradoxically increase work of breathing 1, 3
  • Using BiPAP in deteriorating GBS patients based on success in other neuromuscular diseases—this has resulted in acute cyanosis and emergency intubations 4
  • Relying on IVC indices for volume assessment in BiPAP patients with IPAP >15 cmH2O or EPAP >8 cmH2O—positive pressure reverses normal physiology and makes these measurements unreliable 3

References

Guideline

Role of BiPAP in Managing Increased Respiratory Work of Breathing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

BiPAP Use in DNI Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Compressibility Index vs Distensibility Index in BiPAP Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

BiPAP in early guillain-barré syndrome may fail.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2006

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Can BiPAP (Bilevel Positive Airway Pressure) be used during sleep?
What is the recommended Bipap (Bilevel Positive Airway Pressure) spacing protocol for patients requiring therapy?
What are the indications for BiPAP (Bilevel Positive Airway Pressure) therapy?
What are the guidelines for arranging BiPAP (Bilevel Positive Airway Pressure) or CPAP (Continuous Positive Airway Pressure) for patients requiring respiratory support at home?
What is the difference between BiPAP (Bilevel Positive Airway Pressure) and CPAP (Continuous Positive Airway Pressure) for non-invasive ventilation support?
What is the most appropriate lipid-lowering regimen for a 56-year-old patient with hypertension, stage 2 chronic kidney disease (CKD), and a family history of sudden cardiac death, who has elevated low-density lipoprotein cholesterol (LDL-C) levels?
What antibiotics should be started in a patient with Chronic Obstructive Pulmonary Disease (COPD) presenting with severe hyponatremia and suspected atypical pneumonia?
For which patient is varicella vaccination indicated: a patient with diabetes mellitus (DM) and chronic liver disease (CLD) who received one dose of the vaccine 2 years ago and has no evidence of immunity, a pregnant individual with Human Immunodeficiency Virus (HIV) and a compromised immune system, a patient who underwent cardiac and renal transplantation 6 months ago with no documented immunity, or a patient with leukemia receiving chemotherapy who received one dose of the vaccine at a younger age and has no evidence of immunity?
What is the recommended treatment for a patient with labial Herpes Simplex Virus (HSV) infection?
Is the recommended dose of methotrexate (disease-modifying antirheumatic drug (DMARD)) for an adult patient with rheumatoid arthritis 25mg weekly or 2.5mg weekly?
What is the diagnostic approach for an older adult with suspected dementia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.